Central Monitoring – Central Monitoring Summit

CONFERENCE UPDATE: All conferences are being conducted as scheduled. We are aware there is a chance of inclement weather. We will update all participants if there are any changes made.

Successfully introducing new drugs and therapies in a quicker and more cost-effective manner starts in the most complex phase on of drug development; the clinical phase. The implementation of risk-based monitoring increases the overall quality of data while providing better oversight of patient safety. With the introduction of centralized monitoring in a risk-based monitoring approach, pharmaceutical companies are able to embrace a real-time overview of data and risk detection.The Central Monitoring Summit will arm delegates with the tools they need to optimize existing clinical operation platforms and build quality into the design for a sound central monitoring foundation. Join your colleagues and our expert speaking staff as they provide in-depth insights into shifting your monitoring processes from an excessive concentration of data to risk-driven monitoring that uses central monitoring and technology enablement.

Event Sponsors

Testimonials

While I’m 10+ years in the industry (18 months in Quality), I learned a lot! Great networking.

Senior Clinical Quality Manager, NOVARTIS

Discussions, presentations, interactions have provided a clear picture of common issues

VP Quality, ALTASCIENCES

I was able to find weaknesses in my process that I will need to review

Director, CQA, TREVENA

Members could share struggles, challenges, and ideas. It was also a good forum to build my network. As the conference went on, people seemed to share more lessons learned, shared learning, and tip/tricks. I liked this. It’s more helpful to share challenges that are followed by solutions.